This pilot study tests whether a daily herbal supplement made from Lindera obtusiloba can improve quality of life for people with non-small cell lung cancer who are receiving PD-1 or PD-L1 inhibitor immunotherapy. About 20 adults will take the supplement for 8 weeks alongside the…
Phase: NA • Sponsor: Jun-Yong Choi • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC